318 related articles for article (PubMed ID: 23083525)
1. Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users.
Sidney S; Cheetham TC; Connell FA; Ouellet-Hellstrom R; Graham DJ; Davis D; Sorel M; Quesenberry CP; Cooper WO
Contraception; 2013 Jan; 87(1):93-100. PubMed ID: 23083525
[TBL] [Abstract][Full Text] [Related]
2. Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Jick S; Kaye JA; Li L; Jick H
Contraception; 2007 Jul; 76(1):4-7. PubMed ID: 17586129
[TBL] [Abstract][Full Text] [Related]
3. Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Mar; 73(3):223-8. PubMed ID: 16472560
[TBL] [Abstract][Full Text] [Related]
4. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
5. Nonoral combined hormonal contraceptives and thromboembolism: a systematic review.
Tepper NK; Dragoman MV; Gaffield ME; Curtis KM
Contraception; 2017 Feb; 95(2):130-139. PubMed ID: 27771476
[TBL] [Abstract][Full Text] [Related]
6. Risk of venous thromboembolism and the use of dienogest- and drospirenone-containing oral contraceptives: results from a German case-control study.
Dinger J; Assmann A; Möhner S; Minh TD
J Fam Plann Reprod Health Care; 2010 Jul; 36(3):123-9. PubMed ID: 20659364
[TBL] [Abstract][Full Text] [Related]
7. Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users.
Cole JA; Norman H; Doherty M; Walker AM
Obstet Gynecol; 2007 Feb; 109(2 Pt 1):339-46. PubMed ID: 17267834
[TBL] [Abstract][Full Text] [Related]
8. Combined hormonal contraception and venous thromboembolism.
Martínez F; Avecilla A
Eur J Contracept Reprod Health Care; 2007 Jun; 12(2):97-106. PubMed ID: 17559006
[TBL] [Abstract][Full Text] [Related]
9. [Hormonal contraception and vascular risk: CNGOF Contraception Guidelines].
Plu-Bureau G; Sabbagh E; Hugon-Rodin J
Gynecol Obstet Fertil Senol; 2018 Dec; 46(12):823-833. PubMed ID: 30389542
[TBL] [Abstract][Full Text] [Related]
10. Combined hormonal contraceptives and venous thromboembolism: putting the risks into perspective.
Raymond EG; Burke AE; Espey E
Obstet Gynecol; 2012 May; 119(5):1039-44. PubMed ID: 22525916
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular and general safety of a 24-day regimen of drospirenone-containing combined oral contraceptives: final results from the International Active Surveillance Study of Women Taking Oral Contraceptives.
Dinger J; Bardenheuer K; Heinemann K
Contraception; 2014 Apr; 89(4):253-63. PubMed ID: 24576793
[TBL] [Abstract][Full Text] [Related]
12. [Venous thromboembolism in adolescents associated with fourth-generation oral contraceptives].
Botzenhardt S; Toni I; Rascher W; Neubert A
Klin Padiatr; 2013 Sep; 225(5):268-76. PubMed ID: 23979828
[TBL] [Abstract][Full Text] [Related]
13. Another flawed database study.
Szarewski A; Mansour D; Shapiro S
Contraception; 2013 Apr; 87(4):505-6. PubMed ID: 23261232
[No Abstract] [Full Text] [Related]
14. [Combined hormonal contraception in cycles artificially extended].
Bustillos-Alamilla E; Zepeda-Zaragoza J; Hernández-Ruiz MA; Briones-Landa CH
Ginecol Obstet Mex; 2010 Jan; 78(1):37-45. PubMed ID: 20931801
[TBL] [Abstract][Full Text] [Related]
15. Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users.
Dore DD; Norman H; Loughlin J; Seeger JD
Contraception; 2010 May; 81(5):408-13. PubMed ID: 20399947
[TBL] [Abstract][Full Text] [Related]
16. Thrombotic risks of oral contraceptives.
Rott H
Curr Opin Obstet Gynecol; 2012 Aug; 24(4):235-40. PubMed ID: 22729096
[TBL] [Abstract][Full Text] [Related]
17. Hormonal contraception and venous thromboembolism.
Lidegaard Ø; Milsom I; Geirsson RT; Skjeldestad FE
Acta Obstet Gynecol Scand; 2012 Jul; 91(7):769-78. PubMed ID: 22568831
[TBL] [Abstract][Full Text] [Related]
18. Risk of venous thromboembolism with drospirenone in combined oral contraceptive products.
Sehovic N; Smith KP
Ann Pharmacother; 2010 May; 44(5):898-903. PubMed ID: 20371756
[TBL] [Abstract][Full Text] [Related]
19. Risk of thromboembolism in women taking ethinylestradiol/drospirenone and other oral contraceptives.
Seeger JD; Loughlin J; Eng PM; Clifford CR; Cutone J; Walker AM
Obstet Gynecol; 2007 Sep; 110(3):587-93. PubMed ID: 17766604
[TBL] [Abstract][Full Text] [Related]
20. Cerebral venous sinus thrombosis in users of four hormonal contraceptives: levonorgestrel-containing oral contraceptives, norgestimate-containing oral contraceptives, desogestrel-containing oral contraceptives and the contraceptive patch.
Jick SS; Jick H
Contraception; 2006 Oct; 74(4):290-2. PubMed ID: 16982227
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
